The rapid growth of healthcare spending, combined with accommodating financial markets, has made Hong Kong the perfect springboard into Asia for new biotech businesses. Acknowledging this, experts at the recent “Maximising Business Opportunities through Hong Kong on Healthcare Technology and Investment Collaboration” webinar, organised by the Hong Kong Trade Development Council (HKTDC), set out to explain how European healthcare start‑ups and other companies can leverage the city’s strategic position, especially its close ties with Mainland China, to benefit from the rapid growth of healthcare spending in the region.
Learn about latest market updates and insights to empower your business.